A Multi-Component Weight Loss Intervention to Improve Outcomes of Total Knee Replacement
1 other identifier
interventional
24
1 country
1
Brief Summary
Obesity, specifically BMIs ≥35 or 40 kg/m2, are associated with an increased probability of poor outcomes of Total Knee Arthroplasty (TKA) including increased pain, risk for infection, poor joint function, and increased rates of hospital readmissions. Several orthopedic and public health organizations recommend weight loss prior to TJA for individuals with overweight/obesity. However, empirical evidence suggesting the effectiveness of pre-surgical weight loss on surgical and functional outcomes of TKA is extremely limited and is based primarily on non-randomized observational studies. Thus, to gain further insight regarding the feasibility and potential effectiveness of pre-surgical weight loss on outcomes of TKA, the proposed pilot trial will randomize 30 patients (age 50-75 yrs., BMI 35\<40 kg/m2) scheduled for TKA through The University of Kansas Health System Department of Orthopedics and Sports Medicine (KUOrtho) to a multi-component weight loss (3-mo. pre-TKA, very low-calorie diet) and maintenance intervention (3-mo. post TKA, conventional maintenance diet) or standard care control which will include no dietary or weight loss advice. The weight loss/maintenance interventions will include reduced energy intake or energy intake prescribed for weight loss maintenance, increased physical activity, and individual behavior counseling. Outcomes will be assessed 1) baseline, i.e., 3 mos. prior to surgery, 2) 3 mos. i.e., at the completion of the weight loss intervention prior to TKA, 3) within a minimum of 2 weeks post TKA, and 4) 3 mos. post-TKA, i.e., after completion of the weight maintenance intervention to assess the feasibility and effectiveness of a remotely delivered multi-component pre-TKA weight loss and a post-TKA weight maintenance intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 6, 2023
CompletedStudy Start
First participant enrolled
May 1, 2023
CompletedFirst Posted
Study publicly available on registry
May 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 9, 2025
CompletedSeptember 17, 2025
September 1, 2025
2 years
March 6, 2023
September 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Participant Retention Feasibility
Feasibility will be based on retention of ≥ 80% participants (i.e., \<20% participant dropout).
6 Months
Participant Attendance Feasibility
Feasibility will be based on ≥ 80% attendance at behavioral counseling sessions.
6 Months
Secondary Outcomes (5)
Knee and Lower Extremity Physical Function (OARSI Test)
6 Months
Fat Mass (kg)
6 Months
Fat Free Mass (kg)
6 Months
Body Weight (kg)
6 Months
Self reported knee function
6 Months
Study Arms (2)
Standard Care Control
NO INTERVENTIONStandard care
Intervention
EXPERIMENTALMulti-component weight loss intervention
Interventions
The intervention group will receive weekly 1-on-1 health coaching with a very-low calorie nutrition plan prior to total knee replacement and a conventional weight maintenance nutrition plan after surgery.
Eligibility Criteria
You may qualify if:
- Age: 50-75 years
- BMI: 35 to ≤40 kg/m2
- Patient of KU Health System Department of Orthopedics and Sports Medicine (KUOrtho)meeting all requirements for TKA surgery.
- TKA surgical date scheduled ≥3 mos. from consent
- Own a Bluetooth enabled computer, tablet, or smart phone with the ability to join remote telehealth sessions and sync study self-monitoring devices.
You may not qualify if:
- Weight loss ≥10 pounds in previous 6 months
- Dairy/milk protein allergy
- Currently pregnant/breastfeeding or planning to become pregnant during the study
- Currently being treated for an eating disorder or history of an eating disorder diagnosis
- Pacemaker
- Current Cancer
- Diabetes Type 1 (insulin dependent)
- Hyperuricemia (untreated)
- Inflammatory bowel disease (active)
- Liver disease requiring protein restriction
- Myocardial infarction within last 3 months
- Abnormal ECG
- Renal insufficiency.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Kansas Medical Centerlead
- South Dakota State Universitycollaborator
Study Sites (1)
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steve Herrmann, PhD
University of Kansas Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 6, 2023
First Posted
May 10, 2023
Study Start
May 1, 2023
Primary Completion
April 30, 2025
Study Completion
September 9, 2025
Last Updated
September 17, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share